Tirbanibulin Ointment 1%, a Novel Inhibitor of Tubulin Polymerization and Src Kinase Signaling , for the Treatment of Actinic Keratosis (AK): Results from Two Pivotal Phase III Studies

Authors :: Steven Kempers
Seth Forman
Andrew Blauvelt
Edward Lain
Suzanne Bruce
Source :: SKIN The Journal of Cutaneous Medicine. 4:s63
Publication Year :: 2020
Publisher :: National Society for Cutaneous Medicine, 2020.
Abstract: not available.

Subjects :: Chemistry
Phase (matter)
Actinic keratosis
medicine
Tubulin polymerization
medicine.disease
Molecular biology
Proto-oncogene tyrosine-protein kinase Src

Full Text Access

Tools